RA CAPITAL MANAGEMENT, L.P. - 10%+ Owner at AN2 Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
10%+ Owner
Issuer Symbol
ANTX on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by RA CAPITAL MANAGEMENT, L.P. since 12 Mar 2025

Holdings reported by RA CAPITAL MANAGEMENT, L.P. for AN2 Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 300,853 $324,921 $1.08 09 Aug 2024 Indirect

Transactions reported by RA CAPITAL MANAGEMENT, L.P. for AN2 Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.